Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

X-linked adrenoleukodystrophy (X-ALD) is a severe neurological disease characterized by progressive demyelination within the CNS, adrenal insufficiency, and is associated with an accumulation of saturated very long chain fatty acids in plasma and tissues of patients. iNKT cells, a distinct lineage of T cells recognizing glycolipid antigens through CD1d molecules, exert immunoregulatory functions and can prevent various immune mediated-pathologies. In ALD patients, but not in ALD deficient mice, iNKT cell frequency and CD1d expression on the surface of B cells are slightly decreased. However, such minor differences might not influence the pathogenesis of the disease.

Original publication




Journal article


J Neuroimmunol

Publication Date





204 - 211


Adolescent, Adrenoleukodystrophy, Adult, Aged, Animals, Antigen-Presenting Cells, Antigens, CD1, Antigens, CD1d, Brefeldin A, Child, Cytokines, Disease Models, Animal, Flow Cytometry, Glycoproteins, Glycosphingolipids, Humans, Lipid Metabolism, Male, Mice, Mice, Inbred C57BL, Middle Aged, Natural Killer T-Cells, Protein Synthesis Inhibitors, Young Adult